Medical Robots Market to Reach USD 22.26 Billion by 2032, Growing at a CAGR of 6.58% During 2026–2032

The Global Medical Robots Market was valued at USD 14.28 billion in 2025, advancing to USD 15.19 billion in 2026, and is projected to reach USD 22.26 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.58% over the forecast period. This sustained growth trajectory is rooted in three converging structural forces: the accelerating volume of complex surgical procedures worldwide, the rapid institutionalization of robotic platforms across hospitals and clinics, and the integration of artificial intelligence into next-generation systems. Technological advancements in robotics have moved these platforms from specialty-use investments to standard infrastructure for high-volume surgical specialties, broadening the total addressable market considerably.

Regulatory activity and rising healthcare expenditure have further reinforced commercial momentum. The U.S. Food and Drug Administration granted 510(k) clearance to Intuitive Surgical’s fifth-generation da Vinci 5 platform in March 2024, incorporating over 150 design enhancements including force-feedback instruments and advanced onboard computing. Furthermore, the FDA authorized 253 AI-enabled medical devices in 2024 alone, compared to just 10 in the program’s first decade, reflecting a structural acceleration in regulatory throughput that materially shortens development-to-deployment timelines for next-generation medical robotic systems.

From a segmentation standpoint, AI-Based Robotics leads the technology landscape with approximately 34% share, driven by peer-reviewed evidence confirming a 40% improvement in surgical precision and a 30% reduction in intraoperative complications in AI-assisted procedures. Moreover, Laparoscopy commands approximately 38% of the application segment, underpinned by robotic platforms’ ability to overcome rigid-instrument and two-dimensional visualization limitations across colorectal, gynaecological, urological, and general surgery procedures.

Regionally, North America leads with, anchored by the world’s highest concentration of FDA-cleared robotic surgical platforms and a reimbursement architecture that actively incentivizes robotic-assisted procedures. Consequently, the Centers for Medicare & Medicaid Services finalized the addition of 547 procedures to the ASC Covered Procedures List effective January 2026, directly expanding the reimbursable procedural surface for robotic surgery across approximately 6,000 ambulatory surgery centers nationwide, reinforcing the region’s structural market leadership through the forecast period, further stated as recent report “Medical Robots Market Analysis, 2026”.

Medical Robots Market Highlights

The Global Medical Robots Market was valued at USD 14.28 billion in 2025, advancing to USD 15.19 billion in 2026, and is projected to reach USD 22.26 billion by 2032, expanding at a CAGR of 6.58% over the forecast period, driven by accelerating surgical procedure volumes, deepening hospital adoption of robotic platforms, and expanding AI integration across surgical, rehabilitation, and diagnostic robotic systems.
North America leads with approximately 40% of global market share in 2025, anchored by the world’s highest concentration of FDA-cleared robotic surgical platforms, a reimbursement architecture that actively incentivizes robotic-assisted procedures, and the U.S. accounting for 52% of all new da Vinci system installations globally in 2024 per Intuitive Surgical’s SEC-filed earnings reports.
AI-Based Robotics is the dominant technology segment with approximately 34% share, supported by peer-reviewed evidence confirming a 40% improvement in surgical precision and a 30% reduction in intraoperative complications in AI-assisted robotic procedures, compelling hospitals to prioritize AI-integrated platforms over conventional systems in capital procurement decisions.
Laparoscopy is the leading application segment with approximately 38% share, driven by robotic platforms’ ability to overcome rigid-instrument and two-dimensional visualization limitations of conventional laparoscopic techniques across colorectal, gynaecological, urological, and general surgery procedures.
The Global Medical Robots Market is moderately consolidated, with the top players collectively accounting for approximately 18% combined share. Intuitive Surgical leads globally, Medtronic holds a strong position across Europe, Latin America, and Asia, and Stryker dominates robotic orthopedic surgery.